|
gptkbp:instanceOf
|
gptkb:disease
leukemia
|
|
gptkbp:affects
|
gptkb:breast
gptkb:thyroid
gptkb:cancer
gptkb:mucosa-associated_lymphoid_tissue
gptkb:skin
salivary gland
stomach
ocular adnexa
|
|
gptkbp:associatedWith
|
gptkb:Helicobacter_pylori_infection
gptkb:Hashimoto's_thyroiditis
autoimmune diseases
Sjogren's syndrome
|
|
gptkbp:canBeDisseminated
|
yes
|
|
gptkbp:canBeIndolent
|
yes
|
|
gptkbp:canBeLocalized
|
yes
|
|
gptkbp:cellOrigin
|
gptkb:B_cell
|
|
gptkbp:commonIn
|
adults
elderly
|
|
gptkbp:diagnosedBy
|
imaging
endoscopy
biopsy
|
|
gptkbp:firstDescribed
|
1983
|
|
gptkbp:fullName
|
Mucosa-associated lymphoid tissue lymphoma
|
|
gptkbp:gender
|
slightly more common in females
|
|
gptkbp:geneticAbnormality
|
API2-MALT1 fusion
t(11;18)(q21;q21) translocation
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MALT lymphoma
|
|
gptkbp:ICD-10_code
|
C88.4
|
|
gptkbp:prognosis
|
generally favorable
|
|
gptkbp:rareIn
|
children
|
|
gptkbp:relapsePossible
|
yes
|
|
gptkbp:riskFactor
|
persistent infection
chronic inflammation
|
|
gptkbp:stagingSystem
|
Ann Arbor system
|
|
gptkbp:subspecies
|
extranodal marginal zone B-cell lymphoma
|
|
gptkbp:symptom
|
abdominal pain
fatigue
weight loss
dyspepsia
|
|
gptkbp:transformsInto
|
diffuse large B-cell lymphoma
|
|
gptkbp:treatment
|
antibiotics
radiation therapy
chemotherapy
immunotherapy
|
|
gptkbp:WHOClassification
|
mature B-cell neoplasm
|
|
gptkbp:bfsParent
|
gptkb:Helicobacter_pylori_infection
gptkb:Helicobacter_pylori
|
|
gptkbp:bfsLayer
|
6
|